title: Alternative lengthening of telomeres in human glioma stem cells.
abstract: Cancer stem cells are increasingly recognized as major therapeutic targets. We report here the isolation of glioma stem cells (GSCs) maintaining telomere length through a telomerase-independent mechanism known as alternative lengthening of telomeres (ALTs). TG20 cells were isolated from a glioblastoma multiforme, which had the ALT phenotype. They have no detectable telomerase activity and extremely long and heterogeneous telomeres colocalizing with promyelocytic leukemia bodies. The cancer stem cell potential of TG20 cells was confirmed based on their expression of neural stem cell markers, their capacity of in vitro long-term proliferation and to form intracranial tumors in immune-deficient mice. Interestingly, we found that both in vitro and in vivo TG20 cells were significantly more resistant to ionizing radiation than GSCs with telomerase activity. Analysis of DNA damage foci, DNA double-strand breaks repair, and chromosome instability suggest that radiation resistance was related to interference of ALT pathway with DNA damage response. Therefore, our data show for the first time that the ALT pathway can confer to cancer stem cells the capacity to sustain long-term proliferation as telomerase activity and importantly may also affect treatment efficiency. TG20 cells are thus the first cellular model of GSCs displaying ALT and should prove to be useful for the development of specific treatment strategies.
authors.affiliation: Laboratoire de RadioPathologie, Institut de Radiobiologie Cellulaire et Moléculaire, CEA, Fontenay-aux-Roses, France.
authors.forename: David C
authors.initials: DC
authors.lastname: Silvestre
authors.forename: José R
authors.initials: JR
authors.lastname: Pineda
authors.forename: Françoise
authors.initials: F
authors.lastname: Hoffschir
authors.forename: Jeanne-Marie
authors.initials: JM
authors.lastname: Studler
authors.forename: Marc-André
authors.initials: MA
authors.lastname: Mouthon
authors.forename: Françoise
authors.initials: F
authors.lastname: Pflumio
authors.forename: Marie-Pierre
authors.initials: MP
authors.lastname: Junier
authors.forename: Hervé
authors.initials: H
authors.lastname: Chneiweiss
authors.forename: François D
authors.initials: FD
authors.lastname: Boussin
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D001932:Brain Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D005260:Female; D005910:Glioma / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D008822:Mice, Transgenic; D008875:Middle Aged; D014411:Neoplastic Stem Cells / Q000378:metabolism* / Q000473:pathology; D016615:Telomere / Q000235:genetics / Q000378:metabolism*; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured